← All guides

ADHD medication: what the research actually says

Medication is the best-tested ADHD treatment. It works for most people in the short term, has real but manageable side effects, and is linked to fewer accidents.

Facts checked 24 October 2026 · every claim links to its source

General information, not medical advice. Never start, stop or change a medicine without your prescriber.

How well it works

A 2025 review of 113 trials in about 15,000 adults found only two kinds of treatment clearly beat placebo on core ADHD symptoms, whoever rated them: stimulants and atomoxetine. The effect of stimulants was medium-sized. In children, methylphenidate is usually tried first; in adults, amphetamines did slightly better in a large 2018 comparison.

The two main types

  • Stimulants: methylphenidate (Ritalin, Concerta, Focalin) and amphetamines (Adderall, Vyvanse). They work within an hour and come in short- and long-acting forms.
  • Non-stimulants: atomoxetine (Strattera), viloxazine (Qelbree), guanfacine (Intuniv) and clonidine. They take weeks to work fully, are usually less effective than stimulants, and aren’t controlled drugs. In the US, guanfacine and clonidine are approved for children, not adults.

Side effects

The common ones are lower appetite, trouble sleeping, headaches, and a small rise in pulse and blood pressure. Many ease after the first weeks or with a dose or timing change. Finding the right medicine and dose often takes a few tries; that’s normal, not failure.

Less common but important: stimulants carry an FDA warning about misuse and addiction, so store them safely and never share them. Atomoxetine and viloxazine carry a warning about suicidal thoughts in children and teens, so families should watch for mood changes, especially early on. Rarely, stimulants can trigger hallucinations or mania; tell your prescriber straight away if anything like that happens.

The heart question

A large Swedish study found each year on ADHD medication was linked to about a 4% higher risk of heart and blood-vessel disease, mostly high blood pressure, with the risk rising over the first three years and then levelling off. That is real but small, and it is why your prescriber checks your blood pressure and pulse. Guanfacine and clonidine lower them instead, and must not be stopped suddenly, because blood pressure can rebound; your prescriber will taper them.

Long-term outcomes

These come from population studies, which show links rather than proof, but they are large and consistent. Starting medication was linked to 21% fewer deaths over two years, mainly from fewer accidents and poisonings. Being on medication was also linked to fewer suicide attempts, less substance misuse, fewer car crashes and less crime.

Shortages and children under 6

US shortages of some generic stimulants have continued into 2026; in late 2023, 7 in 10 adults on stimulants had trouble filling a prescription. If your pharmacy is out, ask about another pharmacy, the brand version, a different strength or a different medicine. In 2025 the FDA updated labels to say long-acting stimulants are not approved for children under 6, because young children get higher drug levels and more side effects, especially weight loss.

Want the other options side by side? See Does it work?

Common questions

Does ADHD medication work for adults?

Yes. A 2025 review of 113 trials found stimulants and atomoxetine clearly improved core ADHD symptoms in adults compared with placebo over about 12 weeks.

Is ADHD medication bad for your heart?

A large study linked each year of use to about a 4% higher risk of heart and blood-vessel disease, mostly high blood pressure. The risk is real but small, so prescribers monitor blood pressure and pulse.

What is the difference between stimulants and non-stimulants?

Stimulants work within an hour and have the strongest evidence. Non-stimulants take weeks to work fully, are usually somewhat less effective, and are not controlled drugs.

Sources

  1. Ostinelli et al., Lancet Psychiatry: treatments for adult ADHD (113 trials) (2025)
  2. Cortese et al., Lancet Psychiatry: ADHD medicines compared (2018)
  3. Zhang et al., JAMA Psychiatry: ADHD medication and heart disease (2024)
  4. Farhat et al., Lancet Psychiatry: heart effects of ADHD medicines (2025)
  5. Li et al., JAMA: medication and death rates (2024)
  6. Zhang et al., BMJ: medication and suicide, substance misuse, crashes, crime (Southampton) (2025)
  7. CDC MMWR: trouble filling stimulant prescriptions (2024)
  8. Psychiatric Times: FDA weight-loss warning for under-6s (2025)
Report